Documents & Downloads

(S)-DOTAGA.(SA.FAPi)2

Precursor for Radiopharmaceutical Labeling

(S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, designed for the synthesis of radionuclide drug conjugates (RDCs). These conjugates enable highly specific targeting of biomolecules, making them valuable tools in medical imaging applications. The compound facilitates the incorporation of radionuclides, enhancing the efficacy of diagnostic and therapeutic procedures in oncology and other fields.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2417089-06-4
Applications	Precursor for Radiopharmaceutical Labeling
Formula	C₇₁H₈₃F₄N₁₇O₁₇
Molecular Weight	1522.52
SMILES	N#C[C@@H]1CC(F)(CN1C(CNC(C2=CC=NC3=C2C=C(C=C3)OCCCCNC4=C(C(C4=O)=O)NCCNC(CC[C@H](N5CCN(CCN(CCN(CC5)CC(O)=O)CCNC6=C(C(C6=O)=O)NCCCCOC7=CC8=C(N=CC=C8C(NCC(N9CC(F)(C[C@H]9C#N)F)=O)=O)C=C7)CC(O)=O)C(O)=O)=O)=O)=O)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.